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Abstract This paper provides a review of the literature
on the nervous system involvement incurred by children
and adolescents with chronic kidney disease (CKD), with
a particular focus on neuropsychological functioning. In
addition to an historical overview of earlier literature,
published studies from the past 14 years that address both
central and peripheral nervous system function in children
with CKD are reviewed (1990–2003). These studies span
work in neuroimaging, electrophysiology, and neuropsy-
chology. A key focus for this review is on variables that
might affect neurodevelopmental status in these children.
The paper concludes with suggestions for achieving pro-
gress in the understanding of this complication of kidney
disease in children.
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Introduction
Associations between end-stage renal disease (ESRD) and
neurocognitive dysfunction have been reported for over
25 years. Between 1977 and 1986, approximately 15
publications described dialysis in infants. In these early
studies, approximately 65% of infants were reported to
have developmental delay and 49% encephalopathy [1].
Between 1976 and 1984, the neurocognitive effects of
aluminum-induced neurotoxicity secondary to then cur-
rent treatments for chronic kidney disease (CKD) were
reported [2, 3, 4]. These neurocognitive effects included
seizures, speech disorders, dementia, and a slow electro-
encephalogram (EEG) pattern [2, 3]. These findings were
important for the field in that they encouraged modifi-
cations to the treatment regimen for dialysis patients and
highlighted a confounding factor in the relationship be-
tween CKD and neurocognitive integrity. By 1990 the use
of aluminum was generally eliminated with improved
dialysis water purification techniques and avoidance of
aluminum-containing medications. In the early 1990s,
erythropoietin was introduced into standard practice, re-
sulting in improved anemia management for children and
adults with ESRD and a diminution of anemia-related
EEG and cognitive deficits reported in the adult ESRD
population [5, 6, 7].
The purpose of this paper is to review the contempo-
rary published literature that focuses on the neurological
impact of CKD in children. Papers selected for this re-
view have been published from 1990 to the present, and
were selected to coincide with the improvements in
treatment, including the diminution of aluminum expo-
sure and availability of erythropoietin that occurred circa
1990. These studies span work in neuroimaging, electro-
physiology, and neuropsychology to address central ner-
vous system (CNS) function. We also present available
studies addressing the integrity of the peripheral nervous
system.
Central nervous system studies
Neuroimaging
Imaging of the brain with computed tomography and
magnetic resonance imaging (MRI) has been used to
document the structural impact of ESRD in children.
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atrophy are obtained from a report of 13 children with
chronic renal failure from infancy. Brain atrophy was
reported in 3 (23%) of these patients [8]. Publications
with a focus on certain disease groups with a high risk for
CNS disease, such as cystinosis, Lowe syndrome, and
congenital nephrotic syndrome, estimate the prevalence
of cerebral atrophy to range between 15% and 100% [9,
10, 11]. A recent study by Qvist et al. [11] described a
cohort of 33 children, largely composed of children with
ESRD from congenital nephrotic syndrome, tested an
average of 6 years after renal transplant. MRI documented
CNS infarcts or ischemic changes from both silent and
clinically significant cerebrovascular events in 19 (58%).
Although relevant for children with CKD, the frequency
of brain structure abnormalities in these specific disorders
may be greater than in a general pediatric CKD popula-
tion with a variety of renal diseases.
Electrophysiology findings
Three reports of EEG findings in a cohort of children
with CKD have been published since 1990. In one study
focal and paroxysmal EEG abnormalities were observed
in 12 (36%) of 33 children after renal transplant, with 5
(15%) receiving anticonvulsant therapy [11]. The second
report of 14 patients documented unspecified EEG ab-
normalities in 6 (42%) [8]. This study also documented a
normal auditory brain stem evoked response in 12 of 12
children tested [8]. Hurkx et al. [12] evaluated 22 chil-
dren with chronic renal insufficiency (CRI) and dialysis
dependence using somatosensory evoked potential of the
right median nerve. They reported an increased interpeak
latency (N13–N20) suggesting a delayed thalamocortical
conduction. No differences in CRI versus dialysis sub-
groups were found. Investigations of adults with ESRD
demonstrate that these tools are sensitive to kidney dis-
ease-related effects and may prove useful in future pe-
diatric studies [5, 6, 13].
Neuropsychology findings
Table 1 provides a brief description of 11 published
studies that have been conducted over the past 15 years,
with follow-up discussion on each of the studies within
the broad domains of cognition listed below. These
studies have employed samples ranging from 9 to 62 in-
fants, children, and adolescents with CKD. The subjects
experienced different types of treatment for their CKD
(e.g., hemodialysis, peritoneal dialysis, kidney transplant,
conservative). The research design varied (e.g., longitu-
dinal, pre-post transplant, control groups) and different
kinds of assessment methodology were used (e.g., infant
development batteries, IQ batteries, specific measures
of cognition, experimental tasks). In this regard, draw-
ing specific conclusions for neuropsychological findings
will be tentative, at best, but should provide guidance to
clinicians and researchers as to how the field should move
forward within this assessment domain.
General neurocognitive function
In infants and toddlers neurodevelopmental testing is
conducted and analyzed in broad categories of overall
development, mental development, and motor develop-
ment. Hulstijn-Dirkmaat et al. [14] compared the general
development in 15 toddlers receiving conservative ther-
apy (CRI) with 16 dialysis-dependent children. The
children with CRI had a better developmental index
compared with the dialysis-dependent children (mean€
standard deviation 90.3€14.3 vs. 67.6€17.3) [14]. Leder-
mann et al. [15] evaluated the long-term outcome of in-
fants requiring peritoneal dialysis. In this study, 2 of 8
(25%) young children demonstrated developmental delay.
Warady et al. [16] evaluated 28 infants at 1 year of age,
all of whom were dialysis dependent. Of these 28 infants,
6 (21%) scored in the low-average or impaired range of
general development. Based on these studies, approxi-
mately 20%–25% of children less than 5 years of age with
CKD might be expected to show general developmental
delays [8, 15, 16].
For older children, IQ is the typical measure of general
cognitive function. In the sample of children studied with
CKD, the distribution of IQ scores is shifted downward
compared with the normal population, with low-average
(IQ 80–89) and average (IQ 90–109) range scores pre-
dominating [11, 14, 15, 16, 17, 18, 19, 20]. In a study of
62 children with ESRD, dialysis and transplant combined,
Brouhard et al. [21] described a significantly lower IQ in
the children with kidney disease compared with their
sibling controls. In 19 children with a mean age of
6.6€1.3 years who had ESRD from infancy, Warady et al.
[16] reported a relatively intact IQ, with 15 of 19 (79%) in
the average range. In this group, 13 of 18 (72%) achieved
average verbal IQ scores, while only 10 (56%) scored in
the average range in the nonverbal subtest [16]. When
comparing transplanted patients with dialysis-dependent
patients, variable results have been reported. Lawry et al.
[18] compared 13 transplanted children with 11 dialysis-
dependent children in a cross-sectional study and found a
higher mean IQ in the transplant group (103.0€11.97 vs.
92.9€16.86). Conversely, Brouhard et al. [21] compared
36 transplant and 26 dialysis-dependent children in their
cross-sectional study and found no significant difference
between these patient groups. In aggregate it appears that
general cognitive function is impaired in children with
CKD, but the published literature is inadequate to fully
characterize this effect with respect to CKD modality and
differences between verbal and non-verbal IQ [11, 16, 19,
22].
833Table 1 Cognitive functioning in children and adolescents with end-stage renal disease (ESRD), 1990–2003 (CKD chronic kidney
disease, SD standard deviation, CAPD continuous ambulatory peritoneal dialysis)
Author/date Sample features Comparison
group
Findings
Davis et al. 1990 [28] n=37 Pre-post
transplant
design
Mental development
20 Dialysis at pre-transplant
evaluation
Improved from pre- (mean=77.0, range 50–116) to
post-transplant (mean=91.4, range 50–117)
17 Conservative at pre-transplant
evaluation
Motor development
Mean age at transplant=17.6 months Improved from pre- (mean=68.7, range 50–86) to
post-transplant (mean=85.6, range 65–109)
Cognition
No change from pre- (mean=92.0) to post-transplant
(mean=90.4)
Overall development worse with early onset of ESRD
Fennell et al. 1990
[22]
n=56 n=56 healthy
children
Cognition
Testing at
6-month
intervals
Decreased verbal ability in CKD
Mean age=13.6 years Visual motor skills
Mean age of CKD onset=6.05 years Decreased in CKD
Modality: Memory and learning
Hemodialysis (7) Decreased in CKD
Peritoneal dialysis (12) Loss of function over time
Kidney transplant (10) Attention
Conservative (27) No differences between CKD and controls
Lawry et al. 1994
[18]
n=24 Transplant
compared
with dialysis
plus conser-
vative
Cognition
Modality: IQ: no differences between dialysis plus conservative
(mean=92.91, SD=16.86) vs. transplant (mean=103.00,
SD=11.97)
Dialysis (9) Correlation between age at onset of illness and IQ
(r=0.49)
Conservative (2) Achievement
Kidney transplant (13) Dialysis plus conservative less than transplant in maths
(P=0.020), reading (P=0.028), and written language
(P=0.028)
Elzouki et al. 1994
[8]
N=15 None Developmental screening
Modality: 3 of 15 with developmental delay
Dialysis (6)
Transplant (3)
Conservative (6)
Hulstijn-Dirkmaat
et al. 1995 [14]
n=31 None Developmental index
Mean age=2.5 years Testing every
6 months
Conservative (mean=90.3, SD=14.3) greater than ESRD
(mean=67.6, SD=17.3)
Modality: Verbal, perceptual performance, and quantitative scales
Dialysis (16) No change over time
Conservative (15)
Mendley and Zelko
1999 [19]
n=9 Pre-post
transplant
design
Cognition (baseline only)
Full-scale IQ mean=91.6
Mean age at pre-transplant
testing=14.2 years
Verbal IQ mean=91.4
Mean age at post-transplant
testing=15.8 years
Performance IQ mean=95.1
Pre-transplant modality: Attention
Peritoneal dialysis (5) Improvement in sustained attention 1-year post-transplant
(P=0.039)
Hemodialysis (3) Executive functioning
Conservative (1) Improvement in mental processing speed 1 year post
transplant (P=0.008)
Mean age of onset of
ESRD=11.9 years
Memory
Mean duration of ESRD prior to
transplant=2.5 years
Improvement in working memory 1 year post transplant
(P=0.016)
Warady et al. 1999
[16]
n=28 infants Longitudinal
design
Development, general
Modality: 6 of 28 children below the average range at 1 year of age
CAPD at 3 months of age Cognition
Transplant at mean
age=2.1€0.8 years
Verbal IQ: 5 of 18 children below the average range at
4 years of age
Mean age at follow-
up=7.8€2.8 years
(range 2.5–12.0 years)
Non-verbal IQ: 8 of 18 children below the average range
at 4 years of age
1 child within impaired range on both verbal and non-
verbal IQ
834Attention and executive function
The findings in the pediatric CKD literature are mixed
with respect to attention and executive function [11, 19,
22]. Fennell et al. [22] reported no differences in mea-
sures of sustained attention between children with all
treatment modalities of CKD combined and matched
controls. Conversely, Mendley and Zelko [19] docu-
mented longitudinal improvements in sustained attention
(pre-transplant 2.19€1.29 vs. post-transplant 2.95€1.33,
P=0.04) and mental processing speed (pre-transplant
2.28€0.72 vs. post-transplant 1.64€0.31 s, P=0.008)
1 year after transplant in 9 children. After renal transplant,
Qvist et al. [11] reported no overall group deficits of at-
tention in 33 children compared with the normative
population [standard deviation score (SDS)= 0.2€0.4],
although 24% of the sample showed generalized attention
deficits.
Language
The prevalence of hearing loss among children with CKD
is approximately 18%, and unrecognized or delayed di-
agnosis of hearing impairment may impede language
development [11, 23]. Children with known hearing loss
Table 1 (continued)
Author/date Sample features Comparison
group
Findings
Ledermann et al.
2000 [15], Madden
et al. 2003 [17]
n=16 infants with ESRD Longitudinal
design
Development, general
Mean age at start of dialysis=
0.38 years (range 0.02–1 year)
2 of 8 school-aged children had general delays
Duration of dialysis=17.3 months
(range=1–59 months)
2 of 8 children <5 years of age had general delays
Mean age at assessment=5.84 (range
1.58–12.00 years)
Cognition
IQ: 67% in average range, and 20% in low-average
range (mean=86.5, range 50–102)
Lower IQ scores for children with co-morbid diagnoses
(mean=67.0) than for those with ESRD alone
(mean=94.2)
Attention
7 of 14 children with hyperactivity problems
Social-behavioral
6 of 14 children displaying conduct problems
Brouhard et al. 2000
[21]
n=62 n=62 siblings Cognition
Mean age: 13.8€0.4 years IQ: ESRD less than siblings
Modality: 26 dialysis, 36 transplant No difference in dialysis vs. transplant
Academic achievement
ESRD less than controls for all measures of spelling,
reading, and mathematics
No difference dialysis vs. transplant
Correlation between age of diagnosis and academic
achievement
Correlation between parental education and academic
achievement
Qvist et al. 2002 [11] n=33 transplant recipients None Cognition
Mean age at assessment=8 years
(range=7–12 years)
Verbal IQ: mean=87.5
Non-verbal IQ: mean=87.5
IQ range
Low: 3/33
Low-average: 14/33
Average: 14/33
Above average: 2/33
Neuropsychological battery
No overall group deficits with attention, language,
memory, or visuospatial abilities when compared with
normative population
Neuropsychological deficits
Attention: 8 of 33 children
Language: 2 of 33 children
Memory: 6 of 33 children
Visuospatial: 8 of 33 children
Motor function
Hemiplegia: 3 of 33 children
Bilateral infarction: 1 of 33
Cerebral palsy: 1 of 33
Auditory function
2 of 33 children with moderate sensorineural hearing loss
835tend to be excluded from studies of cognitive function,
and so their challenges are not likely to be fully reflected
in the published literature [17]. Fennell et al. [22] docu-
mented deficits with verbal abstracting abilities in their
matched control design for children with CKD. Qvist et
al. [11] documented no overall group deficits of language
compared with the normative population (SDS= 0.2€
0.4), with only 6% of children showing evidence of
generalized language deficits. More research needs to be
conducted before determining whether language abilities
will prove to be an area of concern for children with
CKD, particularly with respect to potential delays sec-
ondary to hearing impairment.
Visuospatial abilities
Compared with a matched control population, early
studies by Fennell et al. [22] documented deficits in vi-
sual-motor abilities in a cohort of 56 children with CKD.
Qvist et al. [11] documented no overall group deficits
with visuospatial abilities in 33 transplant recipients when
compared with the normative population (SDS= 0.5€
0.5); however, 24% of the cases did show generalized
visuospatial deficits.
Memory
In a heterogeneous sample of children with CKD, Fennell
et al. [22] reported lower memory scores for children with
CKD compared with controls. In addition, a general loss
of memory function over time was observed in 26 children
with all treatment modalities of CKD over a 12-month
testing period [24]. After kidney transplantation, Qvist et
al. [11] reported no overall group deficits with memory
compared with the normative population (SDS= 0.4€0.5),
although 20% of the cases displayed generalized memory
deficits. Conversely, Mendley and Zelko [19] documented
longitudinal improvements in working memory in 9 chil-
dren 1 year after transplant compared with the pre-trans-
plant evaluation.
Academic achievement
Academic achievement in children with CKD is vulnera-
ble to deficits in each cognitive domain noted above as
well as an increased frequency of school absences. In a
study by Lawry et al. [18], the combined dialysis and
CRI group (n=11) with a mean chronological age of
14.9€3.3 years achieved at an age equivalent of 13.8€5.8
in mathematics, 15.6€7.7 in reading, and 11.2€7.2 in
language. In comparison, the transplant group (n=13) with
a mean chronological age of 13.8€3.2 years, achieved at
an age equivalent of 16.2€7.8 in mathematics, 16.4€7.7 in
reading, and 16.2€9.1 in language. This paper suggested
that transplant recipients may have superior academic
achievement compared with dialysis-dependent children
[18]. Conversely, Brouhard et al. [21] compared the aca-
demic achievement of dialysis and transplant patients and
normal sibling controls. They reported no difference in
academic achievement between dialysis and transplant
groups. However, the combined ESRD group of dialysis
and transplant achieved below their sibling controls in
spelling, arithmetic, and reading [21]. Observational stud-
ies of academic placement further indicate that regular
education (with or without remedial tutoring) is used for
79%–94% of children with CKD, while 13%–15% receive
special education services not related to hearing or visual
impairments [11, 16]. This compares with national data in
which approximately 10%–15% of students receive spe-
cial education services [25]. Given the observed frequency
of abnormalities across multiple areas of cognitive func-
tion, the frequency of special education services used by
children with CKD appears low.
Peripheral nervous system
Peripheral neuropathy including diabetic neuropathy and
dialysis-related amyloidosis has been reported in adults
with ESRD [26, 27]. The frequency of peripheral neu-
ropathy in children with CKD can only be grossly esti-
mated based on the following study. Elzouki et al. [8]
assessed nerve conduction velocity in 11 children with
CKD and found 1 (9%) had diminished motor nerve
conduction. Electromyograms performed in 9 of these
patients revealed increased polyphagia of motor unit po-
tentials in 4 (44%) [8]. At present, we are unable to find
additional published studies examining peripheral neu-
ropathies in children with CKD.
Key variables affecting neurodevelopmental
outcomes
CKD is a complex disorder and, similar to other pediatric
disorders, there are undoubtedly a variety of variables that
contribute to the neurodevelopmental status of this pop-
ulation. Key variables presented here are postulates for
the most part as the studies conducted since 1990 have not
been adequately powered to assess multiple influential
factors.
The duration of CKD and the age at onset of CKD may
affect cognition. Two separate studies have reported a
poorer developmental prognosis for children with earlier-
onset ESRD [18, 28]. It has been postulated that this may
be the result of insults to the CNS at particularly vul-
nerable periods in development or the result of continuous
insults over the majority of postnatal life among some
children with long-standing kidney disease. The congen-
ital disorders presenting with kidney disease early in life
may influence the perceived relationship between dura-
tion of CKD and cognition, as these disorders may have
other associated CNS abnormalities, such as pulmonary
hypoplasia and hypoxia associated with obstructive uro-
pathies, or structural anomalies with Joubert syndrome
836and Smith-Lemli-Opitz syndrome [29]. Hulstijn-Dirkmaat
et al. [14] identified the presence of co-morbid conditions
as a risk factor for cognitive impairment based on mean
IQ scored (CKD alone 86.7 vs. CKD with co-morbidity
61.4, P=0.001). Conversely, Fennell et al. [24] found no
correlation between age at onset of ESRD and cognition.
The available data suggest that the duration of CKD and
the age at onset of CKD negatively impact on cognitive
functioning, but it remains unclear how these variables
contribute to the type and severity of cognitive dysfunc-
tion.
Having reached ESRD, the modality of renal re-
placement therapy may have an impact on neurodevel-
opment. Several studies have examined small groups of
children either before and after renal transplant or as a
cross-sectional study comparing renal replacement ther-
apy modality groups [30, 31]. Fennell et al. [24] com-
pared 10 transplant, 7 hemodialysis, and 12 peritoneal
dialysis patients. Patients in both the transplant and
peritoneal dialysis groups tended to have better attention
and memory skills when compared with the performance
of hemodialysis patients. Additional investigation is war-
ranted to determine the differential effect of hemodialysis
and peritoneal dialysis among children with ESRD with
current dialysis adequacy standards [32, 33, 34]. From
previous studies, a hypothesis can be formulated that
motor skills, memory, attention, and mental processing
may improve after renal transplantation [11, 16, 21].
Although existing literature suggests that a successful
renal transplant may diminish the adverse developmental
effects of ESRD, these same studies document the type
and frequency of residual deficits in pediatric renal
transplant recipients to be greater than in the normative
American population [11, 16, 21].
Complications of CKD such as anemia, hypertension,
and malnutrition likely affect neurodevelopment. Anemia
has been shown to slow the cognitive event related po-
tential in adults with CKD (mean hematocrit=23.7%) and
impair cognitive function among otherwise healthy chil-
dren aged 6–11 years with hemoglobin levels less than
11.8 g/dl [6, 35]. The optimal hemoglobin for cognitive
function in children with CKD remains to be determined.
The effects of hypertension on cognition may be related
to the degree of blood pressure elevation, brain injury
consequent to hypertensive or hypotensive episodes, and
side effects of antihypertensive therapy. A recent study by
Lande et al. [36] analyzed National Health and Nutrition
Examination Survey III (NHANES III) data comparing
217 children with systolic blood pressure greater than or
equal to the 90th percentile for age and gender with 4,860
normotensive children. The NHANES III study used sub-
tests of the Wechsler Intelligence Scale for Children and
reading and arithmetic subtests of a standardized aca-
demic achievement test. In this study, results suggested
that hypertension was associated with lower scores in
subtests representing memory, attention, and arithmetic.
Furthermore, malnutrition in young infants without kid-
ney or other chronic disease has been linked to impaired
brain growth and developmental delay [37, 38, 39]. Sig-
nificant effort has been applied to the nutritional support
of children with CKD. However, in national registries of
children with CKD, the mean weight z-score is 1.0–1.4
standard deviations below the American age-matched
mean, and mean height z-scores are approximately 1.6
standard deviations below the American age-matched
mean [40]. Anemia, hypertension, and malnutrition are
likely key factors contributing to the cognitive deficits of
children with CKD.
Children with CKD are at risk for additional disorders
that may accompany congenital kidney disease. Prema-
turity occurs with a greater frequency in children with
congenital kidney disease and is associated with a greater
frequency of CNS injuries and later developmental defi-
cits [11, 41]. Socioeconomic status and parental education
have a known impact on academic achievement among all
children [42]. Although not unique to children with CKD,
the identification of poor socioeconomic status or limited
parental education may trigger additional educational
evaluation and or services for children with CKD in these
families. School absences are increased in children with
CKD due to the need for outpatient medical visits, hos-
pitalizations, hemodialysis, and acute illness [20]. Finally,
the CKD population is at excess risk for sensory deficits,
including congenital and acquired hearing impairment
(9%-18%) and visual impairment, although the latter has
not been examined thoroughly [11, 43]. All of these
factors may contribute to the neurodevelopmental dys-
function of children with kidney disease.
Conclusions
Emergent findings appear to apply to three broad groups
of children and adolescents: mild-to-moderate CKD, di-
alysis-dependent children, and transplant-dependent chil-
dren. What is known about children with mild-to-moderate
CKD is severely limited, with no focused studies ad-
dressing their neurodevelopmental needs. More is known
about the pediatric dialysis population, with deficits in the
areas of attention, language, visual-spatial abilities, and
memory. However, the differentiation of problems that
may relate to disease-specific variables, such as age at
onset of kidney failure, anemia, and hypertension, remain
relatively unknown and modestly examined at best. For
the transplant-dependent group, cognitive deficits appear
to persist, supporting the conclusion that the transplant
does not result in complete neurocognitive “recovery.”
The low frequency of peripheral neuropathy in chil-
dren with CKD observed clinically and reported in a
single study may be attributed to the low prevalence of
diseases with microvascular complications such as dia-
betes mellitus, advanced atherosclerosis, and dialysis-re-
lated amyloidosis [8]. This pediatric advantage may be
lost as patients survive into young adulthood. It is un-
likely that purely pediatric follow-up studies will be able
to characterize this potential late-term complication.
Given the expected long-term patient survival of
children with CKD, established guidelines for the provi-
837sion of renal replacement therapy for children, and the
data provided by studies among children with CKD, we
believe that an organized, adequately powered approach
toward the characterization of the neurodevelopmental
impact of CKD is warranted [32, 33, 34, 44]. Ideally, this
study or set of studies will include measures of neu-
roimaging, electrophysiology, and neuropsychology. Fu-
ture research in this area should characterize potential risk
factors, such as age at onset of disease, anemia manage-
ment, and hypertension to advance our understanding of
the magnitude of cognitive dysfunction and aid the
identification of modifiable mediators of CNS deficits in
children with CKD.
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